Toshifumi Mikayama
Director/Miembro de la Junta en KYOWA KIRIN CO. LTD. .
Origen de la red de primer grado Toshifumi Mikayama.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 50 | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Toshifumi Mikayama a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| KIRIN HOLDINGS COMPANY, LIMITED | Beverages: Alcoholic | Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor Chief Executive Officer Director/Board Member Comptroller/Controller/Auditor Director of Finance/CFO Director/Board Member President Comptroller/Controller/Auditor | |
| University of Tokyo | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Kirin Co., Ltd. (Japan)
 Kirin Co., Ltd. (Japan) Beverages: AlcoholicConsumer Non-Durables Part of Kirin Holdings Co., Ltd., Kirin Co., Ltd. is a company based in Tokyo, Japan. The Japanese company engages in manufacturing and marketing alcohol and non-alcohol beverages. | Beverages: Alcoholic | Comptroller/Controller/Auditor President Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
Kirin Brewery Co. Ltd.
 Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Beverages: Alcoholic | Corporate Officer/Principal President Director/Board Member Corporate Officer/Principal | |
Kyowa Hakko Bio Co., Ltd.
 Kyowa Hakko Bio Co., Ltd. Pharmaceuticals: OtherHealth Technology Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Other | Comptroller/Controller/Auditor Director/Board Member Chief Executive Officer | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SAN MIGUEL BREWERY, INC. | Beverages: Alcoholic | Director/Board Member Director/Board Member Director/Board Member | |
Kyowa Kirin Ltd.
 Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President | |
Lion Pty Ltd.
 Lion Pty Ltd. Beverages: AlcoholicConsumer Non-Durables Lion Pty Ltd. engages in the production, distribution, and selling of food and beverage products. It offers beer, wine, cider, milk, cheese, yogurts, desserts, and dairy products. The company was founded in 1840 and is headquartered in Sydney, Australia. | Beverages: Alcoholic | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Kato Memorial Bioscience Foundation | Investment Trusts/Mutual Funds | Chairman Director/Board Member | |
Stirling Anglian Pharmaceuticals Ltd.
 Stirling Anglian Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Kelso Pharma Ltd., Stirling Anglian Pharmaceuticals Ltd. was founded in 2013 and is a medicines optimization company based in Glasgow, UK. The British company is committed to medicines optimization and has sourced and developed a portfolio of medicines to help the NHS curb waste across a range of conditions that currently place unnecessary and avoidable strain on the healthcare system. Stirling Anglian Pharmaceuticals was acquired by Kelso Pharma Ltd. on January 12, 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Director/Board Member Chief Executive Officer | |
| SAN MIGUEL BREWERY HONG KONG LIMITED | Beverages: Alcoholic | Director/Board Member Director/Board Member | |
Kirin Business System Co., Ltd.
 Kirin Business System Co., Ltd. Information Technology ServicesTechnology Services Part of Kirin Holdings Co., Ltd., Kirin Business System Co., Ltd. is a Japanese company that provides IT systems development, operation, and maintenance services. The company is based in Tokyo, Japan. | Information Technology Services | Director/Board Member Director/Board Member | |
Kyowa Kirin Services Ltd.
 Kyowa Kirin Services Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1989, Kyowa Kirin Services Ltd. is a subsidiary of Kirin Holdings Co., Ltd. that researches and develops drugs. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Kelso Pharma Ltd.
 Kelso Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kelso Pharma Ltd. manufactures pharmaceuticals. The company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 2020. The CEO is Harry Thomas Stratford. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kyowa Kirin GmbH
 Kyowa Kirin GmbH Pharmaceuticals: MajorHealth Technology Part of Kirin Holdings Co., Ltd., Kyowa Kirin GmbH is a German company that manufactures and supplies pharmaceutical products. The company is based in Dusseldorf, Germany. The company was founded in 2011. The CEO is Norberto Villarrasa Justicia. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
BBI Diagnostics Group 2 Plc
 BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Chairman | |
Archimedes Pharma UK Ltd.
 Archimedes Pharma UK Ltd. Medical/Nursing ServicesHealth Services Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| Keio University | College/University | Undergraduate Degree Undergraduate Degree | |
| BTG | Pharmaceuticals: Major | Director/Board Member Chairman | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
Helsinn Holding SA
 Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002. | Hospital/Nursing Management | Director/Board Member | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman | |
FSI SGR SpA
 FSI SGR SpA Investment ManagersFinance FSI SGR SpA (FSI) also known as Fondo Strategico Italiano, is an independent private equity firm. The firm was founded in 2016 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
Helsinn Healthcare SA /Venture/
 Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor | |
| Yokohama National University | College/University | Undergraduate Degree | |
| CORE CONCEPT TECHNOLOGIES INC. | Information Technology Services | Director/Board Member | |
| University of Tokyo Faculty of Law & Graduate Schools for Law | College/University | Graduate Degree | |
| HAMAMATSU PHOTONICS K.K. | Electronic Components | Director/Board Member | |
| CYFUSE BIOMEDICAL K.K. | Biotechnology | Director/Board Member | |
Anderson Mori & Tomotsune
 Anderson Mori & Tomotsune Miscellaneous Commercial ServicesCommercial Services Anderson Mori & Tomotsune is a Japanese company that provides legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ROLAND DG CORPORATION | Industrial Machinery | Independent Dir/Board Member | |
| Pharmacia & Upjohn SpA | Corporate Officer/Principal | ||
Diadem SpA
 Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Hitotsubashi | College/University | Undergraduate Degree | |
Hajime Construction Co., Ltd.
 Hajime Construction Co., Ltd. HomebuildingConsumer Durables Hajime Construction Co., Ltd. engages in the construction business. The company was founded by Kazuo Iida on February 13, 1967 and is headquartered in Tokyo, Japan. | Homebuilding | Chief Administrative Officer | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Consultant / Advisor | |
Leave a Nest Capital KK
 Leave a Nest Capital KK Investment ManagersFinance Leave a Nest Capital KK (Leave a Nest Capital) is a venture capital subsidiary of Leave a Nest Co Ltd founded in 2020. The firm is headquartered in Tokyo, Japan. | Investment Managers | Director/Board Member | |
| PERSEUS PROTEOMICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| SHIMADZU CORPORATION | Medical Specialties | Director/Board Member | |
| Yamaguchi University | College/University | Doctorate Degree | |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Medical/Nursing Services | Director/Board Member | |
| MOCHIDA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Japón | 25 |
| Reino Unido | 13 |
| Estados Unidos | 4 |
| Suiza | 4 |
| Italia | 4 |
Sectorial
| Health Technology | 19 |
| Consumer Non-Durables | 7 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Health Services | 5 |
Operativa
| Director/Board Member | 196 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 50 |
| Chairman | 43 |
| Chief Executive Officer | 21 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| John Brown | 36 |
| Peter Allen | 27 |
| David Ebsworth | 26 |
| Francesco Granata | 24 |
| Jim O'Shea | 16 |
| Andrew Firth McLean | 13 |
| Allan Mark Watson | 11 |
| Shobu Nishitani | 10 |
| Yoshihisa Suzuki | 10 |
| Takeshi Minakata | 9 |
| Abdul Mullick | 9 |
| Yoshinori Isozaki | 9 |
| Jeffrey Humphrey | 8 |
| Takashi Oyamada | 8 |
| Akihiro Ito | 8 |
- Bolsa de valores
- Insiders
- Toshifumi Mikayama
- Conexiones Empresas
